Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
NT-157
i
Other names:
NT-157, NT157, NT 157
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Purple Biotech
Drug class:
STAT3 inhibitor, Insulin receptor substrate protein inhibitor
Related drugs:
‹
BBI608 (4)
BP1003 (2)
TTI-101 oral (2)
JSI-124 (2)
EC-70124 (1)
INB03 (1)
YHO-1701 (1)
niclosamide (1)
stattic (1)
CM-728 (0)
DUET-101 (0)
DUET-201 (0)
GLG-302 (0)
HJC0152 (0)
NT219 (0)
OPB-111077 (0)
STAT3 inhibitor (0)
sulforafan alfadex (0)
WP1066 (0)
SK&F106615 (0)
iMX-110 (0)
AZD9150 (0)
ACT001 (0)
BS-HH-002.SA (0)
SHR0302 (0)
VT-11CR (0)
BBI608 (4)
BP1003 (2)
TTI-101 oral (2)
JSI-124 (2)
EC-70124 (1)
INB03 (1)
YHO-1701 (1)
niclosamide (1)
stattic (1)
CM-728 (0)
DUET-101 (0)
DUET-201 (0)
GLG-302 (0)
HJC0152 (0)
NT219 (0)
OPB-111077 (0)
STAT3 inhibitor (0)
sulforafan alfadex (0)
WP1066 (0)
SK&F106615 (0)
iMX-110 (0)
AZD9150 (0)
ACT001 (0)
BS-HH-002.SA (0)
SHR0302 (0)
VT-11CR (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
BCR-ABL1 T315I
Chronic Myeloid Leukemia
BCR-ABL1 T315I
Chronic Myeloid Leukemia
NT-157
Sensitive: D – Preclinical
NT-157
Sensitive
:
D
NT-157
Sensitive: D – Preclinical
NT-157
Sensitive
:
D
FLT3 mutation
Acute Myelogenous Leukemia
FLT3 mutation
Acute Myelogenous Leukemia
ASP7487 + NT-157
Sensitive: D – Preclinical
ASP7487 + NT-157
Sensitive
:
D
ASP7487 + NT-157
Sensitive: D – Preclinical
ASP7487 + NT-157
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login